Raccah, Doran

Publication with MATCHING institution:

Publication with MISMATCHING institution:

• Gerbi A, Maixent JM, Barbey O, ..., Raccah D (1999) Neuroprotective effect of fish oil in diabetic neuropathy. Lipids.
  [IF=0.532, Cited=2, 10419103].
• Darmon P, Raccah D (2015) Options for intensification of basal insulin in type 2 diabetes: Premeal insulin or short-
  acting GLP-1 receptor agonists? None. [IF=None, Cited=3, 26774016].
• Raccah D, Haak TJ, Huet D, ..., Penfornis A (2012) Comparison of stepwise addition of prandial insulin to a basal-bolus
  regimen when basal insulin is insufficient for glycaemic control in type 2 diabetes: results of the OSIRIS study. None.
  [IF=None, Cited=10, 23116646].
• Raccah D (2017) Basal insulin treatment intensification in patients with type 2 diabetes mellitus: A comprehensive
  systematic review of current options. None. [IF=None, Cited=6, 28169086].
• Raccah D, Coste TC, Vague P (2004) [Genetics of diabetic complications: peripheral neuropathy]. Annales
  d'Endocrinologie. [IF=0.817, Cited=3, 15163918].
• Raccah D, Zeitoun C, Lafforgue P, ..., Vague P (1992) [Inflammatory rheumatism flare-up after surgical treatment of
  Cushing's disease: two cases]. Revue de Medecine Interne. [IF=0.209, Cited=5, 1287774].
• Raccah D, Coste T, Cameron NE, ..., Hohman TC (1998) Effect of the aldose reductase inhibitor tolrestat on nerve
  conduction velocity, Na/K ATPase activity, and polyols in red blood cells, sciatic nerve, kidney cortex, and kidney
  medulla of diabetic rats. Journal of Diabetes and its Complications. [IF=0.817, Cited=25, 9618071].
• Raccah D (2006) Importance of blood glucose management in the multifactorial approach of absolute cardiovascular risk in
  type 2 diabetes: the lessons from the Steno 2 study. Diabetes and Metabolism. [IF=1.474, Cited=3, 17375408].
• Raccah D, Hanaire-Broutin H, Sert-Langeron C, ..., Eschwege E (2006) Insulin initiation in type 2 diabetic patients
  admitted in hospital in France and follow-up at 1 year. Diabetes and Metabolism. [IF=1.474, Cited=8, 16799401].
• Varvelo L, Lynd JK, Citty B, ..., Raccah D (2023) Formally Exact Simulations of Mesoscale Exciton Diffusion in a Light-
  Harvesting 2 Antenna Nanoarray. Journal of Physical Chemistry Letters. [IF=1.158, Cited=2, 36947483].
• Million M, Maraninchi M, Henry M, ..., Raoult D (2024) Retraction Note: Obesity-associated gut microbiota is enriched in
  Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii. International Journal of
  Obesity. [IF=1.398, Cited=0, 39075172].
• Raccah D, Dadoun F, Coste T, Vague P (1996) Decreased Na/K ATPase ouabain binding sites in red blood cells of patients
  with insulin-dependent diabetes and healthy north African control subjects: relationship with diabetic neuropathy.
  Hormone and Metabolic Research. [IF=0.743, Cited=7, 8926011].
• Gera T, Chen L, Eisfeld A, ..., Raccah D (2023) Simulating optical linear absorption for mesoscale molecular aggregates:
  An adaptive hierarchy of pure states approach. Journal of Chemical Physics. [IF=1.184, Cited=0, 37125709].
• Citty B, Lynd JK, Gera T, ..., Raccah D (2024) MesoHOPS: Size-invariant scaling calculations of multi-excitation open
  quantum systems. Journal of Chemical Physics. [IF=1.184, Cited=0, 38619062].
• Raccah D, Pettenuzzo-Mollo M, Provendier O, ..., Vague P (1994) Comparison of the effects of captopril and nicardipine
  on insulin sensitivity and thrombotic profile in patients with hypertension and android obesity. CaptISM Study Group.
  Captopril Insulin Sensitivity Multicenter Study Group. American Journal of Hypertension. [IF=0.926, Cited=8, 7986464].
• Raccah D, Huet D, Dib A, ..., Schmitt H (2017) Review of basal-plus insulin regimen options for simpler insulin
  intensification in people with Type 2 diabetes mellitus. Diabetic Medicine. [IF=1.293, Cited=10, 28574177].
• Seino Y, Takami A, Boka G, ..., Raccah D (2014) Pharmacodynamics of the glucagon-like peptide-1 receptor agonist
  lixisenatide in Japanese and Caucasian patients with type 2 diabetes mellitus poorly controlled on sulphonylureas
  with/without metformin. Diabetes, Obesity and Metabolism. [IF=1.314, Cited=18, 24524806].
• Raccah D (2008) Options for the intensification of insulin therapy when basal insulin is not enough in type 2 diabetes
  mellitus. Diabetes, Obesity and Metabolism. [IF=1.314, Cited=23, 18577159].
• Gallian P, Berland Y, Olmer M, ..., de Lamballerie X (1999) TT virus infection in French hemodialysis patients: study of
  prevalence and risk factors. Journal of Clinical Microbiology. [IF=1.711, Cited=44, 10405397].
• Halimi S, Raccah D, Schweizer A, Dejager S (2010) Role of vildagliptin in managing type 2 diabetes mellitus in the
  elderly. Current Medical Research and Opinion. [IF=0.784, Cited=16, 20441397].
• Selam JL, Bergman RN, Raccah D, ..., Charles MA (1990) Determination of portal insulin absorption from peritoneum via
  novel nonisotopic method. Diabetes. [IF=1.654, Cited=29, 2227110].
• Selam JL, Raccah D, Jean-Didier N, ..., Charles MA (1992) Randomized comparison of metabolic control achieved by
  intraperitoneal insulin infusion with implantable pumps versus intensive subcutaneous insulin therapy in type I diabetic
  patients. Diabetes Care. [IF=4.781, Cited=32, 1737542].
• Raccah D, Lassmann-Vague V, Alessi MC, ..., Vague P (1994) Intraperitoneal insulin administration does not modify
  plasminogen activator inhibitor 1 levels in IDDM patients. Diabetes Care. [IF=4.781, Cited=3, 7956648].
• Lassmann-Vague V, Belicar P, Raccah D, ..., Vague P (1995) Immunogenicity of long-term intraperitoneal insulin
  administration with implantable programmable pumps. Metabolic consequences. Diabetes Care. [IF=4.781, Cited=13, 7497859].
• Vialettes B, Paquis-Fluckinger V, Silvestre-Aillaud P, ..., Vanuxen D (1995) Extra-pancreatic manifestations in diabetes
  secondary to mitochondrial DNA point mutation within the tRNALeu(UUR) gene. Diabetes Care. [IF=4.781, Cited=19, 7555536].
• Raccah D, Fabreguetts C, Azulay JP, Vague P (1996) Erythrocyte Na(+)-K(+)-ATPase activity, metabolic control, and
  neuropathy in IDDM patients. Diabetes Care. [IF=4.781, Cited=19, 8725852].
• Raccah D, Janand-Delenne B, Vague P (1999) [Non-insulin-dependent diabetes]. None. [IF=None, Cited=0, 10218402].
• Raccah D, Gallice P, Pouget J, Vague P (1992) Hypothesis: low Na/K-ATPase activity in the red cell membrane, a potential
  marker of the predisposition to diabetic neuropathy. None. [IF=None, Cited=0, 1327887].
• Raccah D (2006) [Management of diabetes in elderly cardiac patients]. None. [IF=None, Cited=0, 17236471].
• Raccah D, Disdier P, Roybet D, ..., Vague P (1995) [Bradycardia during treatments of weight loss]. Presse Medicale.
  [IF=0.434, Cited=0, 7501608].
• Raccah D, Lamotte-Jannot MF, Issautier T, Vague P (1994) Effect of experimental diabetes on Na/K-ATPase activity in red
  blood cells, peripheral nerve and kidney. None. [IF=None, Cited=0, 8001715].
• Raccah D (1998) [Physiopathology of diabetic neuropathies. Functional exploration of peripheral involvement]. Diabetes
  and Metabolism. [IF=1.474, Cited=0, 9881236].

Publication with MISSING institution:

• Lassmann-Vague V, Belicar P, Alessis C, ..., Vague P (1996) Insulin kinetics in type I diabetic patients treated by
  continuous intraperitoneal insulin infusion: influence of anti-insulin antibodies. Diabetic Medicine. [IF=1.293,
  Cited=8, 8973887].
• Raccah D (2007) Comment on: Evans JMM, Ogston SA, Emslie-Smith A, Morris AD (2006) Risk of mortality and adverse
  cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin.
  Diabetologia 49:930-936. Diabetologia. [IF=2.486, Cited=3, 17351766].
• Gerbi A, Barbey O, Raccah D, ..., Maixent JM (1997) Alteration of Na,K-ATPase isoenzymes in diabetic cardiomyopathy:
  effect of dietary supplementation with fish oil (n-3 fatty acids) in rats. Diabetologia. [IF=2.486, Cited=39, 9165216].
• Vague P, Dufayet D, Coste T, ..., Raccah D (1997) Association of diabetic neuropathy with Na/K ATPase gene polymorphism.
  Diabetologia. [IF=2.486, Cited=26, 9165217].
• De La Tour DD, Raccah D, Jannot MF, ..., Vague P (1998) Erythrocyte Na/K ATPase activity and diabetes: relationship with
  C-peptide level. Diabetologia. [IF=2.486, Cited=37, 9754827].
• Djemli-Shipkolye A, Raccah D, Pieroni G, ..., Gerbi A (2003) Differential effect of omega3 PUFA supplementations on
  Na,K-ATPase and Mg-ATPase activities: possible role of the membrane omega6/omega3 ratio. Journal of Membrane Biology.
  [IF=0.733, Cited=11, 12532275].
• Ben Amara N, Tourniaire F, Maraninchi M, ..., Darmon P (2014) Independent positive association of plasma β-carotene
  concentrations with adiponectin among non-diabetic obese subjects. European Journal of Nutrition. [IF=1.304, Cited=12, 24906472].
• Issautier T, Kovacic H, Gallice P, ..., Crevat A (1994) Modulation defect of sodium pump evidenced in diabetic patients
  by a microcalorimetric study. Clinica Chimica Acta. [IF=1.141, Cited=5, 7988032].
• Vague P, Raccah D, Juhan-Vague I (1992) Hemobiology, vascular disease, and diabetes with special reference to impaired
  fibrinolysis. Metabolism: Clinical and Experimental. [IF=2.576, Cited=4, 1574009].
• Marlier S, Raccah D, Disdier P, ..., Weiller PJ (1995) [Thyrotoxic periodic paralysis. Discussion of the role of Na-K-
  ATPase, apropos of a case]. Revue de Medecine Interne. [IF=0.209, Cited=4, 7740232].
• Penfornis A, Borot S, Raccah D (2008) Therapeutic approach of type 2 diabetes mellitus with GLP-1 based therapies.
  Diabetes and Metabolism. [IF=1.474, Cited=13, 18640590].
• Hanaire H, Lassmann-Vague V, Jeandidier N, ..., Guerci B (2008) Treatment of diabetes mellitus using an external insulin
  pump: the state of the art. Diabetes and Metabolism. [IF=1.474, Cited=24, 18951116].
• Schaepelynck P, Darmon P, Molines L, ..., Raccah D (2011) Advances in pump technology: insulin patch pumps, combined
  pumps and glucose sensors, and implanted pumps. None. [IF=None, Cited=20, 22208717].
• Bégu-Le Corroller A, Valéro R, Moutardier V, ..., Vialettes B (2008) Aggressive multimodal therapy of sporadic malignant
  insulinoma can improve survival: a retrospective 35-year study of 12 patients. Diabetes and Metabolism. [IF=1.474,
  Cited=16, 18556231].
• Molines L, Darmon P, Raccah D (2010) Charcot's foot: newest findings on its pathophysiology, diagnosis and treatment.
  None. [IF=None, Cited=30, 20570543].
• Guerci B, Monnier L, Serusclat P, ..., Dejager S (2012) Continuous glucose profiles with vildagliptin versus sitagliptin
  in add-on to metformin: results from the randomized Optima study. None. [IF=None, Cited=44, 22809630].
• Coste T, Pierlovisi M, Leonardi J, ..., Raccah D (1999) Beneficial effects of gamma linolenic acid supplementation on
  nerve conduction velocity, Na+, K+ ATPase activity, and membrane fatty acid composition in sciatic nerve of diabetic
  rats. Journal of Nutritional Biochemistry. [IF=1.201, Cited=13, 15539317].
• Lassmann-Vague V, Raccah D (2006) Alternatives routes of insulin delivery. Diabetes and Metabolism. [IF=1.474,
  Cited=20, 17130810].
• Conrath J, Giorgi R, Ridings B, Raccah D (2005) Metabolic factors and the foveal avascular zone of the retina in
  diabetes mellitus. Diabetes and Metabolism. [IF=1.474, Cited=7, 16357790].
• Rebsomen L, Pitel S, Boubred F, ..., Tsimaratos M (2006) C-peptide replacement improves weight gain and renal function
  in diabetic rats. Diabetes and Metabolism. [IF=1.474, Cited=25, 16799398].
• Million M, Maraninchi M, Henry M, ..., Raoult D (2011) Obesity-associated gut microbiota is enriched in Lactobacillus
  reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii. International Journal of Obesity.
  [IF=1.398, Cited=322, 21829158].
• Conrath J, Giorgi R, Raccah D, Ridings B (2005) Foveal avascular zone in diabetic retinopathy: quantitative vs
  qualitative assessment. Eye. [IF=2.022, Cited=119, 15258601].
• Janand-Delenne B, Chagnaud C, Raccah D, ..., Vague P (1998) Visceral fat as a main determinant of plasminogen activator
  inhibitor 1 level in women. None. [IF=None, Cited=60, 9578235].
• Gerbi A, Maixent JM, Barbey O, ..., Raccah D (1998) Alterations of Na,K-ATPase isoenzymes in the rat diabetic
  neuropathy: protective effect of dietary supplementation with n-3 fatty acids. Journal of Neurochemistry. [IF=1.089,
  Cited=29, 9681464].
• Gerbi A, Sennoune S, Pierre S, ..., Maixent JM (1999) Localization of Na,K-ATPase alpha/beta isoforms in rat sciatic
  nerves: effect of diabetes and fish oil treatment. Journal of Neurochemistry. [IF=1.089, Cited=14, 10428069].
• Djemli-Shipkolye A, Gallice P, Coste T, ..., Vague P (2000) The effects ex vivo and in vitro of insulin and C-peptide on
  Na/K adenosine triphosphatase activity in red blood cell membranes of type 1 diabetic patients. Metabolism: Clinical and
  Experimental. [IF=2.576, Cited=21, 10909997].
• Jannot MF, Raccah D, De La Tour DD, ..., Vague P (2002) Genetic and environmental regulation of Na/K adenosine
  triphosphatase activity in diabetic patients. Metabolism: Clinical and Experimental. [IF=2.576, Cited=12, 11887161].
• Lassmann-Vague V, Raccah D, Pugeat M, ..., Vague P (1994) SHBG (sex hormone binding globulin) levels in insulin
  dependent diabetic patients according to the route of insulin administration. Hormone and Metabolic Research. [IF=0.743,
  Cited=8, 7835829].
• Vague P, Coste TC, Jannot MF, ..., Tsimaratos M (2004) C-peptide, Na+,K(+)-ATPase, and diabetes. None. [IF=None,
  Cited=65, 15198370].
• Gerbi A, Maixent JM, Ansaldi JL, ..., Raccah D (1999) Fish oil supplementation prevents diabetes-induced nerve
  conduction velocity and neuroanatomical changes in rats. Journal of Nutrition. [IF=1.215, Cited=33, 9915901].
• Tsimaratos M, Coste TC, Djemli-Shipkolye A, ..., Raccah D (2001) Gamma-linolenic acid restores renal medullary thick
  ascending limb Na(+),K(+)-ATPase activity in diabetic rats. Journal of Nutrition. [IF=1.215, Cited=9, 11739860].
• Sejil S, Janand-Delenne B, Avierinos JF, ..., Lassmann-Vague V (2006) Six-year follow-up of a cohort of 203 patients
  with diabetes after screening for silent myocardial ischaemia. Diabetic Medicine. [IF=1.293, Cited=6, 17054593].
• Philippe J, Raccah D (2009) Treating type 2 diabetes: how safe are current therapeutic agents? International Journal of
  Clinical Practice. [IF=0.665, Cited=39, 19196370].
• Rebsomen L, Khammar A, Raccah D, Tsimaratos M (2008) C-Peptide effects on renal physiology and diabetes. None. [IF=None,
  Cited=8, 18509500].
• Vague P, Raccah D (1992) The syndrome of insulin resistance. None. [IF=None, Cited=16, 1306511].
• Jannot MF, Raccah D, Dufayet de la Tour D, ..., Vague P (1999) Relationship between neuropathy, hypertension and red
  blood cell Na/K ATPase in patients with insulin-dependent diabetes mellitus. Diabetes and Metabolism. [IF=1.474,
  Cited=0, 10335422].
• Jannot-Lamotte MF, Raccah D (2000) [Management of diabetes during corticosteroid therapy]. Presse Medicale. [IF=0.434,
  Cited=0, 10701409].
• Granel B, Serratrice J, Mohamed H, ..., Weiller PJ (2001) Pickwickian syndrome and vanishing finger pebbles. None.
  [IF=None, Cited=0, 11295945].
• Tsimarato M, Coste TC, Djemli-Shipkolye A, ..., Raccah D (2001) Evidence of time-dependent changes in renal medullary
  Na,K-ATPase activity and expression in diabetic rats. Cellular and Molecular Biology. [IF=0.489, Cited=0, 11354996].
• Djemli-Shipkolye A, Coste T, Raccah D, ..., Gerbi A (2001) Na,K-atpase alterations in diabetic rats: relationship with
  lipid metabolism and nerve physiological parameters. Cellular and Molecular Biology. [IF=0.489, Cited=0, 11355004].
• Serratrice J, Granel B, Swiader L, ..., Weiller PJ (2002) Interference of dapsone in HbA1c monitoring of a diabetic
  patient with polychondritis. Diabetes and Metabolism. [IF=1.474, Cited=0, 12522333].
• Scelles V, Raccah D, Alessi MC, ..., Vague P (1992) Plasminogen activator inhibitor 1 and insulin levels in various
  insulin resistance states. None. [IF=None, Cited=0, 1563535].
• Coste TC, Gerbi A, Vague P, ..., Raccah D (2004) Peripheral diabetic neuropathy and polyunsaturated fatty acid
  supplementations: natural sources or biotechnological needs? Cellular and Molecular Biology. [IF=0.489, Cited=0, 15672469].
• Detournay B, Raccah D, Cadilhac M, Eschwège E (2005) Epidemiology and costs of diabetes treated with insulin in France.
  Diabetes and Metabolism. [IF=1.474, Cited=0, 16142041].
• Juhan-Vague I, Alessi MC, Raccah D, ..., Vague P (1992) Daytime fluctuations of plasminogen activator inhibitor 1
  (PAI-1) in populations with high PAI-1 levels. Thrombosis and Haemostasis. [IF=1.301, Cited=0, 1615488].
• Vague P, Raccah D (1990) [Natural history of insulin resistance and hyperinsulinism in non-insulin-dependent diabetic
  patients]. None. [IF=None, Cited=0, 2195206].
• Vague P, Raccah D, Scelles V (1995) Hypofibrinolysis and the insulin resistance syndrome. None. [IF=None, Cited=0, 7550531].
• Scelles V, Alessi MC, Raccah D, ..., Vague P (1995) Plasma plasminogen activator inhibitor activity in rats with
  nutritionally induced insulin resistance. Thrombosis and Haemostasis. [IF=1.301, Cited=0, 8585034].
• Vague P, Dufayet D, Lamotte MF, ..., Raccah D (1997) [Genetic factors, Na K ATPase activity and neuropathy in
  diabetics]. Bulletin de l'Academie Nationale de Medecine. [IF=0.258, Cited=0, 9611401].
• Girardin E, Raccah D (1998) [Interaction between converting enzyme inhibitors and hypoglycemic sulfonamides or insulin].
  Presse Medicale. [IF=0.434, Cited=0, 9858970].